Published in Hum Mol Genet on August 29, 2006
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A (2007) 3.50
Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59
Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol (2007) 1.56
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv (2010) 1.24
Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res (2007) 1.20
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2011) 1.18
Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol (2011) 1.16
Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med (2012) 1.16
Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol (2007) 1.15
Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm (2012) 1.14
LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis (2010) 1.11
Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis (2011) 1.01
Progress in defining the molecular biology of age related macular degeneration. Hum Genet (2007) 1.01
High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-β family member growth differentiation factor 6. J Biol Chem (2011) 1.01
Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis (2009) 1.00
CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration. J Ocul Biol Dis Infor (2010) 0.98
Nutritional modulation of age-related macular degeneration. Mol Aspects Med (2012) 0.97
Copy number variations in candidate genes in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.95
Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity. Am J Pathol (2013) 0.94
Pharmacogenetics and age-related macular degeneration. J Ophthalmol (2011) 0.94
Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort. Graefes Arch Clin Exp Ophthalmol (2011) 0.92
VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol (2014) 0.92
Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2014) 0.91
Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis. Mol Vis (2013) 0.88
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. ScientificWorldJournal (2012) 0.86
Conditional gene targeting: dissecting the cellular mechanisms of retinal degenerations. J Ophthalmol (2010) 0.86
Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res (2016) 0.85
Peroxisome proliferator-activated receptor and age-related macular degeneration. PPAR Res (2008) 0.84
New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol (2009) 0.83
Update on the role of genetics in the onset of age-related macular degeneration. Clin Ophthalmol (2011) 0.83
Candidate gene association study for diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis (2014) 0.83
Changes in growth factor expression in normal aging of the rat retina. Exp Eye Res (2007) 0.83
Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration. Genome Med (2015) 0.82
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest Ophthalmol Vis Sci (2014) 0.82
AMD-associated genes encoding stress-activated MAPK pathway constituents are identified by interval-based enrichment analysis. PLoS One (2013) 0.82
Fine mapping of a region of chromosome 11q23.3 reveals independent locus associated with risk of glioma. PLoS One (2012) 0.81
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Clin Perinatol (2014) 0.80
Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology. Clin Ophthalmol (2007) 0.79
Next-generation therapeutic solutions for age-related macular degeneration. Pharm Pat Anal (2012) 0.79
Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population. Jpn J Ophthalmol (2012) 0.78
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice. Indian J Ophthalmol (2007) 0.78
Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.78
Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration in a Turkish population. Int J Ophthalmol (2014) 0.78
Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration. Genet Test Mol Biomarkers (2014) 0.77
Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population. Mol Vis (2013) 0.76
Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol Vis (2009) 0.76
AMD Genetics in India: The Missing Links. Front Aging Neurosci (2016) 0.75
Exploring the role of VEGF in Indian Age related macular degeneration. Ann Neurosci (2015) 0.75
Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients. Meta Gene (2016) 0.75
Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population. J Ophthalmic Vis Res (2016) 0.75
Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis. Dis Markers (2016) 0.75
Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. Acta Pharmacol Sin (2011) 0.75
Autophagy and KRT8/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress. Autophagy (2017) 0.75
Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis. Br J Ophthalmol (2016) 0.75
Identification of Padi2 as a novel angiogenesis-regulating gene by genome association studies in mice. PLoS Genet (2017) 0.75
Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol (2004) 1.96
VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci (2008) 1.14
Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron (2012) 1.11
Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol (2009) 1.09
A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J Clin Endocrinol Metab (2013) 1.02
Detection of VEGF-A(xxx)b isoforms in human tissues. PLoS One (2013) 0.95
Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol Vis (2003) 0.91
Analysis of SERPING1 and its association with age-related macular degeneration. Acta Ophthalmol (2011) 0.91
Pseudomonas syringae pv. phaseolicola: from 'has bean' to supermodel. Mol Plant Pathol (2011) 0.90
A compound heterozygous change found in Peters' anomaly. Mol Vis (2005) 0.88
Narrative review of the barriers and facilitators to chlamydia testing in general practice. Aust J Prim Health (2015) 0.87
The chlamydia knowledge, awareness and testing practices of Australian general practitioners and practice nurses: survey findings from the Australian chlamydia control effectiveness pilot (ACCEPt). BMC Fam Pract (2013) 0.84
Joubert syndrome presenting with motor delay and oculomotor apraxia. Case Rep Pediatr (2012) 0.80
The stealth episome: suppression of gene expression on the excised genomic island PPHGI-1 from Pseudomonas syringae pv. phaseolicola. PLoS Pathog (2011) 0.78
Sex education: findings from the Second Australian Study of Health and Relationships. Sex Health (2017) 0.75